$SGMO SANGAMO THERAPEUTICS, INC Insider Trading Week 50/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SANGAMO THERAPEUTICS, INC in week 50/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Option Exercise | A | 14.07 | 75,000 | 1,055,250 | 75,000 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 14.74 | 41,743 | 615,217 | 138,146 | 179.9 K to 138.1 K (-23.20 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Grant | A | 0.00 | 37,500 | 0 | 179,889 | 142.4 K to 179.9 K (+26.34 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 0 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | A | 14.07 | 250,000 | 3,517,500 | 250,000 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 14.79 | 16,000 | 236,677 | 323,467 | 339.5 K to 323.5 K (-4.71 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 16.47 | 9,000 | 148,235 | 339,467 | 348.5 K to 339.5 K (-2.58 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 348,467 | 323.5 K to 348.5 K (+7.73 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Payment of Exercise | F | 14.74 | 96,533 | 1,422,723 | 323,467 | 420 K to 323.5 K (-22.98 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Grant | A | 0.00 | 125,000 | 0 | 420,000 | 295 K to 420 K (+42.37 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 5.03 | 5,000 | 25,150 | 5,000 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 6.41 | 10,000 | 64,100 | 0 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 16.28 | 10,000 | 162,829 | 214,660 | 224.7 K to 214.7 K (-4.45 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 5.03 | 5,000 | 25,150 | 229,660 | 224.7 K to 229.7 K (+2.23 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 6.41 | 10,000 | 64,100 | 224,660 | 214.7 K to 224.7 K (+4.66 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | A | 14.07 | 50,000 | 703,500 | 50,000 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 14.74 | 27,480 | 405,006 | 95,376 | 122.9 K to 95.4 K (-22.37 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 25,000 | 0 | 122,856 | 97.9 K to 122.9 K (+25.55 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | A | 14.07 | 75,000 | 1,055,250 | 75,000 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Payment of Exercise | F | 14.74 | 30,437 | 448,587 | 116,410 | 146.8 K to 116.4 K (-20.73 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Grant | A | 0.00 | 37,500 | 0 | 146,847 | 109.3 K to 146.8 K (+34.29 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 14.07 | 75,000 | 1,055,250 | 750,000 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 14.74 | 40,004 | 589,587 | 210,849 | 250.9 K to 210.8 K (-15.95 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 0.00 | 37,500 | 0 | 250,853 | 213.4 K to 250.9 K (+17.58 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | M | 4.10 | 10,000 | 41,000 | 0 | |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Sell | S | 15.00 | 6,354 | 95,310 | 28,715 | 35.1 K to 28.7 K (-18.12 %) |
Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Buy | M | 4.10 | 10,000 | 41,000 | 35,069 | 25.1 K to 35.1 K (+39.89 %) |